GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (MEX:BMRN) » Definitions » Inventories, Finished Goods

Biomarin Pharmaceutical (MEX:BMRN) Inventories, Finished Goods : MXN11,004 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Biomarin Pharmaceutical Inventories, Finished Goods?

Biomarin Pharmaceutical's quarterly finished goods increased from Jun. 2024 (MXN7,762 Mil) to Sep. 2024 (MXN10,550 Mil) and increased from Sep. 2024 (MXN10,550 Mil) to Dec. 2024 (MXN11,004 Mil).

Biomarin Pharmaceutical's annual finished goods declined from Dec. 2022 (MXN6,870 Mil) to Dec. 2023 (MXN6,457 Mil) but then increased from Dec. 2023 (MXN6,457 Mil) to Dec. 2024 (MXN11,004 Mil).


Biomarin Pharmaceutical Inventories, Finished Goods Historical Data

The historical data trend for Biomarin Pharmaceutical's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomarin Pharmaceutical Inventories, Finished Goods Chart

Biomarin Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,237.91 5,767.29 6,869.53 6,456.53 11,004.18

Biomarin Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,456.53 6,478.85 7,762.19 10,549.79 11,004.18

Biomarin Pharmaceutical Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Biomarin Pharmaceutical Business Description

Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.